These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3895621)

  • 21. Allotypes of complement components C4, C3, C2 and BF in the populations of Tasmania and northeast England.
    Ad'Hiah AH; Mitchell J; Papiha SS
    Gene Geogr; 1996 Aug; 10(2):93-103. PubMed ID: 9049619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple sclerosis: immunogenetic analyses of sib-pair double case families. II. Studies on the association of multiple sclerosis with C2, C4, BF, C3, C6, and GLO polymorphisms.
    Schröder R; Zander H; Andreas A; Mauff G
    Immunobiology; 1983 Mar; 164(2):160-70. PubMed ID: 6552216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extractable nuclear antigen (ENA) autoantibodies in SLE: an immunogenetic relationship with HLA, C4 and Bf alleles.
    Warlow RS; Uko G; McCluskey J; Kay PH; Christiansen FT; Dawkins RL
    Clin Exp Immunol; 1986 Feb; 63(2):419-27. PubMed ID: 3486067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rare variant of complement C4 is seen in high frequency in patients with primary glomerulonephritis.
    Wank R; Schendel DJ; O'Neill GJ; Riethmüller G; Held E; Feucht HE
    Lancet; 1984 Apr; 1(8382):872-4. PubMed ID: 6143186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Localization of the human MHC-linked complement genes between HLA-B and HLA-DR by using HLA mutant cell lines.
    Whitehead AS; Colten HR; Chang CC; Demars R
    J Immunol; 1985 Jan; 134(1):641-3. PubMed ID: 3917284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Complement markers Bf and C4 in multiple sclerosis].
    Fauchet R; Madigand M; Gueguen-Duchesne MY; Papin J; Sabouraud O; Genetet B
    Rev Neurol (Paris); 1984; 140(6-7):422-5. PubMed ID: 6611572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incomplete functional deficiencies of the fourth (C4) and second (C2) components of complement in a patient with linear frontoparietal scleroderma and his family. Deficiencies determined by a gene not linked to human leukocyte antigen system.
    Venneker GT; van Meegen M; de Kok-Nazaruk M; Hulsmans RF; de Waall LP; Bos JD; Asghar SS
    Exp Clin Immunogenet; 1996; 13(2):104-11. PubMed ID: 9063702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative studies of human C4 phenotypes, their population genetics, and association with HLA-B antigens.
    Rittner C; Zaschke S; Berghoff E; Mollenhauer E; Opferkuch W; Baur MP
    Immunobiology; 1980; 158(1-2):119-28. PubMed ID: 7193647
    [No Abstract]   [Full Text] [Related]  

  • 29. Genetic polymorphisms in the fourth component of complement (C4) and in properdin factor B (BF) in Japanese patients with palmoplantar pustulosis.
    Torii H; Nakagawa H; Ishibashi Y; Tokunaga K; Juji T
    J Dermatol; 1992 Jun; 19(6):353-5. PubMed ID: 1401488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic and environmental influences on serum levels of human C4.
    Averill BK; Bernal JE
    Ann Hum Biol; 1984; 11(2):149-56. PubMed ID: 6732180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production of the third and fourth component of complement (C3, C4) by smooth muscle cells.
    Ueda Y; Nagasawa K; Tsukamoto H; Horiuchi T; Nishizaka H; Ikeda K; Niho Y
    Immunology; 1996 Oct; 89(2):183-8. PubMed ID: 8943712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Genetics of complement: recent aspects (author's transl)].
    Hauptmann G
    Ann Immunol (Paris); 1982; 133C(2):211-9. PubMed ID: 7051953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure and expression of murine fourth complement component (C4) and sex-limited protein (Slp).
    Ogata RT
    Immunol Rev; 1985 Oct; 87():101-22. PubMed ID: 3902619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterogeneity in the structural basis of the human complement C4A null allele (C4A Q0) as revealed by HindIII restriction fragment length polymorphism analysis.
    Uring-Lambert B; Vegnaduzzi N; Carroll MC; Tongio MM; Goetz J; Hauptmann G
    FEBS Lett; 1987 Jun; 217(1):65-8. PubMed ID: 2885219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C3, BF and C4 polymorphisms in Tunisians.
    Ayed K; Gorgi Y
    Hum Hered; 1990; 40(6):363-7. PubMed ID: 2083950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphism of the fourth component of complement (C4) and three clinical pictures of hepatitis B virus infection in children.
    Kacprzak-Bergman I; Hałasa J
    Arch Immunol Ther Exp (Warsz); 1997; 45(4):295-300. PubMed ID: 9523004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chido and Rodgers blood groups are distinct antigenic components of human complement C4.
    O'Neill GJ; Yang SY; Tegoli J; Berger R; Dupont B
    Nature; 1978 Jun; 273(5664):668-70. PubMed ID: 78453
    [No Abstract]   [Full Text] [Related]  

  • 38. Population genetics of C4 with the use of complementary DNA probes.
    Edwards JH
    Philos Trans R Soc Lond B Biol Sci; 1984 Sep; 306(1129):405-17. PubMed ID: 6149583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cultured hepatocytes from mouse strains expressing high and low levels of the fourth component of complement differ in rate of synthesis of the protein.
    Rosa PA; Shreffler DC
    Proc Natl Acad Sci U S A; 1983 Apr; 80(8):2332-6. PubMed ID: 6572979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complement C4, factor B and C3 polymorphism in north India.
    Kramer J; Srivastava LM; Ferenczy E; Füst G
    Acta Microbiol Immunol Hung; 1995; 42(3):315-9. PubMed ID: 8548205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.